Toxicity, biodegradation and elimination of polyanhydrides.

[1]  A. Domb,et al.  Ricinoleic acid-based biopolymers. , 1999, Journal of biomedical materials research.

[2]  C T Laurencin,et al.  Preliminary in vivo report on the osteocompatibility of poly(anhydride-co-imides) evaluated in a tibial model. , 1998, Journal of biomedical materials research.

[3]  R. Langer,et al.  Chemical changes during in vivo degradation of poly(anhydride-imide) matrices. , 1998, Biomaterials.

[4]  R. Langer,et al.  Poly(anhydride-co-imides): in vivo biocompatibility in a rat model. , 1998, Biomaterials.

[5]  A. D'emanuele,et al.  Effect of geometry on the erosion characteristics of polyanhydride matrices , 1998 .

[6]  A. Domb,et al.  In Vitro/In Vivo Comparison of Drug Release and Polymer Erosion from Biodegradable P(FAD-SA) Polyanhydrides—A Noninvasive Approach by the Combined Use of Electron Paramagnetic Resonance Spectroscopy and Nuclear Magnetic Resonance Imaging , 1997, Pharmaceutical Research.

[7]  R. Langer,et al.  In vitro degradation characteristics of poly(anhydride‐imides) containing trimellitylimidoglycine , 1997 .

[8]  R. Langer,et al.  Erosion of poly(anhydride‐co‐imides): A preliminary mechanistic study , 1996 .

[9]  Buddy D. Ratner,et al.  Biomaterials Science: An Introduction to Materials in Medicine , 1996 .

[10]  H. Brem,et al.  Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNU , 1996 .

[11]  E. Park,et al.  Effects of model compounds with varying physicochemical properties on erosion of polyanhydride devices , 1996 .

[12]  H. Brem,et al.  Morphological Characterization of Polyanhydride Biodegradable Implant Gliadel® During in Vitro and in Vivo Erosion Using Scanning Electron Microscopy , 1996, Pharmaceutical Research.

[13]  R. Langer,et al.  In vitro degradation characteristics of poly(anhydride imides) containing pyromellitylimidoalanine , 1996 .

[14]  R. Langer,et al.  In vitro bone biocompatibility of poly(anhydride‐co‐imides) containing pyromellitylimidoalanine , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[15]  R. Langer,et al.  Cytotoxicity testing of poly(anhydride-co-imides) for orthopedic applications. , 1995, Journal of biomedical materials research.

[16]  J. Villemure,et al.  Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain. , 1995, Biomaterials.

[17]  A. Domb,et al.  In vivo and in vitro elimination of aliphatic polyanhydrides. , 1995, Biomaterials.

[18]  J. Tamada,et al.  Erosion of a new family of biodegradable polyanhydrides. , 1994, Journal of biomedical materials research.

[19]  J. Tamada,et al.  In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. , 1994, Journal of biomedical materials research.

[20]  A. Domb,et al.  Absorbable biopolymers derived from dimer fatty acids , 1993 .

[21]  R Langer,et al.  Erosion kinetics of hydrolytically degradable polymers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Laurencin,et al.  Osteoblast culture on bioerodible polymers: studies of initial cell adhesion and spread , 1992 .

[23]  D. Lenartz,et al.  Brain biocompatibility of a biodegradable controlled release polymer consisting of anhydride copolymer of fatty acid dimer and sebacic acid , 1992 .

[24]  J. Hilton,et al.  Polymeric controlled release of dexamethasone in normal rat brain , 1991 .

[25]  A. Friedman,et al.  Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. , 1991, Journal of neurosurgery.

[26]  R. Langer,et al.  Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. , 1990, Journal of biomedical materials research.

[27]  R. Langer,et al.  Morphology of polyanhydride microsphere delivery systems. , 1990, Scanning microscopy.

[28]  J. Kost,et al.  Ultrasound-enhanced polymer degradation and release of incorporated substances. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Tamargo,et al.  Brain biocompatibility of a biodegradable, controlled-release polymer in rats. , 1989, Journal of biomedical materials research.

[30]  R. Sawaya,et al.  Intraoperative Chemical Hemostasis in Neurosurgery , 1986, Neurosurgery.

[31]  R Langer,et al.  Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. , 1985, Journal of biomedical materials research.

[32]  A. G. Braun,et al.  Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[34]  R. Ross.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. , 1971 .

[35]  C T Laurencin,et al.  Proliferation, morphology, and protein expression by osteoblasts cultured on poly(anhydride-co-imides). , 1999, Journal of biomedical materials research.

[36]  J. Black,et al.  Biological performance of materials : fundamentals of biocompatibility , 1999 .

[37]  R. Langer,et al.  Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery. , 1998, Biomaterials.

[38]  A. Domb,et al.  Noninvasive in vivo monitoring of drug release and polymer erosion from biodegradable polymers by EPR spectroscopy and NMR imaging. , 1997, Journal of pharmaceutical sciences.

[39]  A. Göpferich,et al.  Mechanisms of polymer degradation and erosion. , 1996, Biomaterials.

[40]  R. Langer,et al.  Predicting drug release from cylindric polyanhydride matrix discs , 1995 .

[41]  S. Shalaby,et al.  Biomedical polymers : designed-to-degrade systems , 1994 .

[42]  J. Villemure,et al.  Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain. , 1994, Biomaterials.

[43]  J. Tamada,et al.  The development of polyanhydrides for drug delivery applications. , 1992, Journal of biomaterials science. Polymer edition.

[44]  J. Domb.  Synthesis and characterization of biodegradable aromatic anhydride copolymers , 1992 .

[45]  R. Tamargo,et al.  Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. , 1989, Selective cancer therapeutics.

[46]  R Langer,et al.  Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. , 1986, Journal of biomedical materials research.

[47]  Valentino J. Stella,et al.  Directed Drug Delivery , 1985, Experimental Biology and Medicine.

[48]  D. Williams,et al.  Fundamental aspects of biocompatibility , 1981 .

[49]  R. Pedley,et al.  Tumour induction by implant materials , 1981 .

[50]  P. Killenberg,et al.  Chapter 8 – Conjugation by Peptide Bond Formation , 1980 .

[51]  T. Skopek,et al.  Quantitative forward mutation assay in Salmonella typhimurium using 8-azaguanine resistance as a genetic marker. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[52]  I. Weiner.  Excretion of Drugs by the Kidney , 1971 .